The data shows the net ingredient cost (NIC) for short-acting insulins in England from 2005 to 2017. In 2016/17 the NIC for short-acting insulins was 104.6 million GBP which is the highest value since 2005.
2005/6 | 58.1 |
2006/7 | 65.4 |
2007/8 | 72.8 |
2008/9 | 80.6 |
2009/10 | 84 |
2010/11 | 86.7 |
2011/12 | 87.9 |
2012/13 | 90.9 |
2013/14 | 94.6 |
2014/15 | 97.6 |
2015/16 | 101.2 |
2016/17 | 104.6 |